Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption.

ABSTRACT:

SUBMITTER: Demeter J 

PROVIDER: S-EPMC7938919 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature